What is the Impact Factor of Parkinsons Disease?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Parkinsons Disease is 2.20, ranking in quartile Q3 of Web of Science (SCIE).

Is Parkinsons Disease indexed in Web of Science or Scopus?

Yes, Parkinsons Disease is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.722 (Q2) and an H-index of 67.

Who publishes Parkinsons Disease and what is the Article Processing Charge (APC)?

Parkinsons Disease is published by Hindawi Limited. The estimated Article Processing Charge (APC) is approximately $3,109 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Parkinsons Disease?

The official ISO-4 abbreviation of Parkinsons Disease is "PARKINSONS DIS-US". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #7,949Gold OA

Parkinsons Disease

Abbreviation (ISO):PARKINSONS DIS-US

•

Identifier (ISSN):2090-8083(Print)

•

Publisher:Hindawi Limited

Official Website Submission Portal Compare

Clarivate IF (2026)

2.2– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2019–2026)

Clarivate IF trend for Parkinsons Disease

WoS Q3

Annual Impact Factor Metric

Current (2026):2.2

Scopus SJR & RankScopus Q2

0.722

#7,949

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

67 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

41articles/year

100% Gold OA•88% Original Research

Aims & Scope

Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.

Primary Research Areas

Clinical Neurology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank180/296

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank176/296

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	180/296	Q3
CLINICAL NEUROLOGY	JCISCIE	176/296	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

8 year

2026Latest

IF2.2

Articles / Year—

Total Citations—

2025

IF2.2

Articles / Year—

Total Citations—

2024

IF2.1

Articles / Year—

Total Citations—

2023

IF3.2

Articles / Year—

Total Citations—

2022

IF3.17

Articles / Year—

Total Citations—

Year	Impact Factor	Articles / Year	Total Citations
2026	2.2	—	—
2025	2.2	—	—
2024	2.1	—	—
2023	3.2	—	—
2022	3.17	—	—
2021	2.704	—	—
2020	2.051	—	—
2019	2.117	—	—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,949Scopus Q2SCImago Profile

Scopus Coverage:2008, 2010-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q2

0.722

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.22

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,109 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations306

3-Year Documents102

Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Neurology (clinical)Q2

Psychiatry and Mental HealthQ2

Neuroscience (miscellaneous)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区CLINICAL NEUROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Parkinsons Disease (abbr: PARKINSONS DIS-US, ISSN: 2090-8083) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by Hindawi Limited in United States. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.722 (Q2), an H-index of 67.

The journal enforces rigorous peer evaluation with an annual output of approximately 41 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,109 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.